Home › Metastatic Cancer › Virginia › Norfolk
Metastatic Cancer clinical trials in Norfolk, VA
3 studies for Metastatic Cancer are looking for participants at sites in and around Norfolk (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RecruitingPhase 3
- Research Site, Norfolk
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecruitingPhase 3
- USO - Virginia Oncology Associates, Norfolk
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RecruitingPhase 3
- Research Site, Norfolk
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Norfolk
- Breast Cancer16 studies
- Bladder Cancer8 studies
- Prostate Cancer8 studies
- Abdominal Aortic Aneurysm7 studies
- Ovarian Cancer7 studies
- Non-Small Cell Lung Cancer7 studies
- Cancer (all types)7 studies
- Heart Failure7 studies
- Cardiovascular Disease7 studies
- Spinal Muscular Atrophy6 studies
- Peripheral Arterial Disease5 studies
- Triple-Negative Breast Cancer5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.